/

Batteries & E-Mobility

/

Vertex Pharmaceuticals

Vertex Pharmaceuticals

Vertex Pharmaceuticals

Verified Nov 2026

Batteries & E-Mobility

·

United States flag

Boston, Massachusetts

·

Since 1989

Vertex Pharmaceuticals is a Boston-based biopharmaceutical company founded in 1989 with 5,000–10,000 employees and revenue exceeding $10 billion. The company discovers, develops, and commercializes small-molecule drugs and gene-editing therapies for serious diseases including cystic fibrosis, sickle cell disease, and beta thalassemia, serving patients and healthcare providers across the Americas, Europe, Asia, and the Middle East.

Vertex Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

1989

Headquarters

United States flag

Boston, Massachusetts

Employees

5,000-10,000

Ownership

Vertex Pharmaceuticals at a glance

Revenue

$10B+

Est. band

Employees

5,000-10,000

Founded

1989

Headquarters

Boston, Massachusetts

Import activity

16

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

16

Named foreign suppliers

12

Top origins

United Kingdom · Belgium · Netherlands · Germany

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Vertex Pharmaceuticals.

What this tells a buyer

The company received pharmaceutical equipment shipments from multiple European suppliers in Switzerland, Germany, the United Kingdom, Italy, Belgium, and the Netherlands, indicating a distributed supply chain for manufacturing and development operations.

Vertex markets approved therapies including TRIKAFTA for cystic fibrosis, CASGEVY as the first FDA-approved CRISPR-based gene therapy for sickle cell disease and beta thalassemia, and JOURNAVX for acute pain management.

In September 2026, Vertex completed the acquisition of Crinetics Pharmaceuticals and expanded its executive leadership team as part of its strategic growth.

Source: US customs bill-of-lading records and public filings · Last verified Nov 16, 2026

STABILITY SIGNALS

Established & active

37 years in operation (founded 1989).

16 US import shipments on record.

Overview

Vertex Pharmaceuticals is a Boston-based biopharmaceutical company founded in 1989 with 5,000–10,000 employees and revenue exceeding $10 billion. The company discovers, develops, and commercializes small-molecule drugs and gene-editing therapies for serious diseases including cystic fibrosis, sickle cell disease, and beta thalassemia, serving patients and healthcare providers across the Americas, Europe, Asia, and the Middle East.

At a glance

Attribute

Detail

Founded

1989

Headquarters

Boston, Massachusetts

Employees

5,000-10,000

Revenue

$10B+ (estimated)

Primary capability

Batteries & E-Mobility

What Vertex Pharmaceuticals makes

Vertex markets approved therapies including TRIKAFTA for cystic fibrosis, CASGEVY as the first FDA-approved CRISPR-based gene therapy for sickle cell disease and beta thalassemia, and JOURNAVX for acute pain management.

Trade and customs footprint

The company received pharmaceutical equipment shipments from multiple European suppliers in Switzerland, Germany, the United Kingdom, Italy, Belgium, and the Netherlands, indicating a distributed supply chain for manufacturing and development operations. US customs bill-of-lading records list 16 inbound shipments across 12 foreign suppliers, with top origins including United Kingdom · Belgium · Netherlands · Germany.

Latest developments

Company details

In September 2026, Vertex completed the acquisition of Crinetics Pharmaceuticals and expanded its executive leadership team as part of its strategic growth. Vertex Pharmaceuticals was founded in 1989, has an estimated 5,000-10,000 employees, and is headquartered in Boston, Massachusetts. On the LightSource stability read it is rated "Established & active": 37 years in operation (founded 1989). 16 US import shipments on record.

Frequently asked questions

What does Vertex Pharmaceuticals make?

Vertex Pharmaceuticals is a Boston-based biopharmaceutical company founded in 1989 with 5,000–10,000 employees and revenue exceeding $10 billion. The company discovers, develops, and commercializes small-molecule drugs and gene-editing therapies for serious diseases including cystic fibrosis, sickle cell disease, and beta thalassemia, serving patients and healthcare providers across the Americas, Europe, Asia, and the Middle East.

Where is Vertex Pharmaceuticals headquartered?

Vertex Pharmaceuticals is headquartered in Boston, Massachusetts (50 Northern Avenue, Boston, Massachusetts, 02210).

When was Vertex Pharmaceuticals founded?

Vertex Pharmaceuticals was founded in 1989.

How big is Vertex Pharmaceuticals?

Vertex Pharmaceuticals has an estimated 5,000-10,000 employees, with revenue in the $10B+ range (estimated).

Does Vertex Pharmaceuticals import from overseas suppliers?

US customs bill-of-lading records show 16 inbound shipments for Vertex Pharmaceuticals, with top origins including United Kingdom · Belgium · Netherlands · Germany.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Boston, Massachusetts (HQ)Headquarters · United States
Boston, Massachusetts (HQ)50 Northern Avenue, Boston, Massachusetts, 02210, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.